APO Research
Talk to an analyst

APO RESEARCH · REPORT

Guaifenesin (API)

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Selected research

Industry Growth & Trends

Global Guaifenesin (API) Industry Growth and Trends Forecast to 2032

1 January 2026103 pages

Choose your research edition.

Industry ResearchGuaifenesin (API) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Guaifenesin (API) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Guaifenesin (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Guaifenesin (API) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Guaifenesin (API) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Global Guaifenesin (API) key players include Granules, Synthokem Labs, Haizhou Pharma, Yuan Cheng Group, Stellar Chemical, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific and North America is the largest market, both with a share about 35%, followed by Europe, with a share about 25 percent. In terms of product, Above 99% is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceuticals.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Guaifenesin (API) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Guaifenesin (API) market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Guaifenesin (API) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Guaifenesin (API).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Guaifenesin (API) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Guaifenesin (API) Market by Company

Granules

Synthokem Labs

Haizhou Pharma

Yuan Cheng Group

Stellar Chemical

Seven Star Pharma

Gennex Lab

Iwaki Seiyaku

Pan Drugs

Delta Synthetic

Smart Pharm

Guaifenesin (API) Segment by Type

98%-99%

Above 99%

Guaifenesin (API) Segment by Application

Pharmaceuticals

Others

Guaifenesin (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guaifenesin (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Guaifenesin (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guaifenesin (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Guaifenesin (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Guaifenesin (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 98%-99% Table 2. Major Company of Above 99% Table 3. Global Guaifenesin (API) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 5. Global Guaifenesin (API) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Guaifenesin (API) Sales Market Share in Value by Type (2021-2026) Table 8. Global Guaifenesin (API) Price by Type (2021-2026) & (USD/Kg) Table 9. Global Guaifenesin (API) Sales by Type (2027-2032) & (MT) Table 10. Global Guaifenesin (API) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Guaifenesin (API) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Guaifenesin (API) Sales Market Share in Value by Type (2027-2032) Table 13. Global Guaifenesin (API) Price by Type (2027-2032) & (USD/Kg) Table 14. North America Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 15. North America Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 17. Europe Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 21. Latin America Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Guaifenesin (API) Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Guaifenesin (API) Sales by Type (2021-2026) & (US$ Million) Table 24. Guaifenesin (API) Industry Trends Table 25. Guaifenesin (API) Industry Drivers Table 26. Guaifenesin (API) Industry Opportunities and Challenges Table 27. Guaifenesin (API) Industry Restraints Table 28. Global Guaifenesin (API) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Guaifenesin (API) Revenue Market Share by Company (2021-2026) Table 30. Global Guaifenesin (API) Sales by Company (2021-2026) & (MT) Table 31. Global Guaifenesin (API) Sales Share by Company (2021-2026) Table 32. Global Guaifenesin (API) Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Guaifenesin (API) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Guaifenesin (API) Major Company Production Sites and Headquarters Table 35. Global Guaifenesin (API) Company, Product Type & Application Table 36. Global Guaifenesin (API) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Guaifenesin (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Guaifenesin (API) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Guaifenesin (API) Sales by Region (2021-2026) & (MT) Table 41. Global Guaifenesin (API) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Guaifenesin (API) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Guaifenesin (API) Sales Market Share in Value by Region (2021-2026) Table 44. Global Guaifenesin (API) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Guaifenesin (API) Sales by Region (2027-2032) & (MT) Table 46. Global Guaifenesin (API) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Guaifenesin (API) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Guaifenesin (API) Sales Market Share in Value by Region (2027-2032) Table 49. Global Guaifenesin (API) Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Guaifenesin (API) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 52. Global Guaifenesin (API) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Guaifenesin (API) Sales Market Share in Value by Application (2021-2026) Table 55. Global Guaifenesin (API) Price by Application (2021-2026) & (USD/Kg) Table 56. Global Guaifenesin (API) Sales by Application (2027-2032) & (MT) Table 57. Global Guaifenesin (API) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Guaifenesin (API) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Guaifenesin (API) Sales Market Share in Value by Application (2027-2032) Table 60. Global Guaifenesin (API) Price by Application (2027-2032) & (USD/Kg) Table 61. North America Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 62. North America Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 64. Europe Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 68. Latin America Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Guaifenesin (API) Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Guaifenesin (API) Sales by Application (2021-2026) & (US$ Million) Table 71. Granules Company Information Table 72. Granules Business Overview Table 73. Granules Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Granules Guaifenesin (API) Product Portfolio Table 75. Granules Recent Development Table 76. Synthokem Labs Company Information Table 77. Synthokem Labs Business Overview Table 78. Synthokem Labs Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Synthokem Labs Guaifenesin (API) Product Portfolio Table 80. Synthokem Labs Recent Development Table 81. Haizhou Pharma Company Information Table 82. Haizhou Pharma Business Overview Table 83. Haizhou Pharma Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Haizhou Pharma Guaifenesin (API) Product Portfolio Table 85. Haizhou Pharma Recent Development Table 86. Yuan Cheng Group Company Information Table 87. Yuan Cheng Group Business Overview Table 88. Yuan Cheng Group Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Yuan Cheng Group Guaifenesin (API) Product Portfolio Table 90. Yuan Cheng Group Recent Development Table 91. Stellar Chemical Company Information Table 92. Stellar Chemical Business Overview Table 93. Stellar Chemical Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Stellar Chemical Guaifenesin (API) Product Portfolio Table 95. Stellar Chemical Recent Development Table 96. Seven Star Pharma Company Information Table 97. Seven Star Pharma Business Overview Table 98. Seven Star Pharma Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Seven Star Pharma Guaifenesin (API) Product Portfolio Table 100. Seven Star Pharma Recent Development Table 101. Gennex Lab Company Information Table 102. Gennex Lab Business Overview Table 103. Gennex Lab Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Gennex Lab Guaifenesin (API) Product Portfolio Table 105. Gennex Lab Recent Development Table 106. Iwaki Seiyaku Company Information Table 107. Iwaki Seiyaku Business Overview Table 108. Iwaki Seiyaku Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Iwaki Seiyaku Guaifenesin (API) Product Portfolio Table 110. Iwaki Seiyaku Recent Development Table 111. Pan Drugs Company Information Table 112. Pan Drugs Business Overview Table 113. Pan Drugs Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Pan Drugs Guaifenesin (API) Product Portfolio Table 115. Pan Drugs Recent Development Table 116. Delta Synthetic Company Information Table 117. Delta Synthetic Business Overview Table 118. Delta Synthetic Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Delta Synthetic Guaifenesin (API) Product Portfolio Table 120. Delta Synthetic Recent Development Table 121. Smart Pharm Company Information Table 122. Smart Pharm Business Overview Table 123. Smart Pharm Guaifenesin (API) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Smart Pharm Guaifenesin (API) Product Portfolio Table 125. Smart Pharm Recent Development Table 126. North America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 127. North America Guaifenesin (API) Sales by Country (2021-2026) & (MT) Table 128. North America Guaifenesin (API) Sales Market Share by Country (2021-2026) Table 129. North America Guaifenesin (API) Sales Forecast by Country (2027-2032) & (MT) Table 130. North America Guaifenesin (API) Sales Market Share Forecast by Country (2027-2032) Table 131. North America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Guaifenesin (API) Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Guaifenesin (API) Market Share by Country (2021-2026) Table 134. North America Guaifenesin (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Guaifenesin (API) Market Share Forecast by Country (2027-2032) Table 136. Europe Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 137. Europe Guaifenesin (API) Sales by Country (2021-2026) & (MT) Table 138. Europe Guaifenesin (API) Sales Market Share by Country (2021-2026) Table 139. Europe Guaifenesin (API) Sales Forecast by Country (2027-2032) & (MT) Table 140. Europe Guaifenesin (API) Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Guaifenesin (API) Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Guaifenesin (API) Market Share by Country (2021-2026) Table 144. Europe Guaifenesin (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Guaifenesin (API) Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Guaifenesin (API) Sales by Country (2021-2026) & (MT) Table 148. Asia-Pacific Guaifenesin (API) Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Guaifenesin (API) Sales Forecast by Country (2027-2032) & (MT) Table 150. Asia-Pacific Guaifenesin (API) Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Guaifenesin (API) Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Guaifenesin (API) Market Share by Country (2021-2026) Table 154. Asia-Pacific Guaifenesin (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Guaifenesin (API) Market Share Forecast by Country (2027-2032) Table 156. Latin America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 157. Latin America Guaifenesin (API) Sales by Country (2021-2026) & (MT) Table 158. Latin America Guaifenesin (API) Sales Market Share by Country (2021-2026) Table 159. Latin America Guaifenesin (API) Sales Forecast by Country (2027-2032) & (MT) Table 160. Latin America Guaifenesin (API) Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Guaifenesin (API) Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Guaifenesin (API) Market Share by Country (2021-2026) Table 164. Latin America Guaifenesin (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Guaifenesin (API) Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Guaifenesin (API) Sales by Country (2021-2026) & (MT) Table 168. Middle East and Africa Guaifenesin (API) Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Guaifenesin (API) Sales Forecast by Country (2027-2032) & (MT) Table 170. Middle East and Africa Guaifenesin (API) Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Guaifenesin (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Guaifenesin (API) Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Guaifenesin (API) Market Share by Country (2021-2026) Table 174. Middle East and Africa Guaifenesin (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Guaifenesin (API) Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Guaifenesin (API) Distributors List Table 179. Guaifenesin (API) Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Guaifenesin (API) Image Figure 2. Global Guaifenesin (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Guaifenesin (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Guaifenesin (API) Sales (2021-2032) & (MT) Figure 5. 98%-99% Image Figure 6. Global 98%-99% Sales YoY Growth (2021-2032) & (MT) Figure 7. Above 99% Image Figure 8. Global Above 99% Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Guaifenesin (API) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Guaifenesin (API) Market Share by Type 2025 VS 2032 Figure 11. North America Guaifenesin (API) Sales Market Share in Volume by Type in 2025 Figure 12. North America Guaifenesin (API) Sales Market Share in Value by Type in 2025 Figure 13. Europe Guaifenesin (API) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Guaifenesin (API) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Guaifenesin (API) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Guaifenesin (API) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Guaifenesin (API) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Guaifenesin (API) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Guaifenesin (API) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Guaifenesin (API) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Guaifenesin (API) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceuticals Image Figure 24. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (MT) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 27. Global Guaifenesin (API) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Guaifenesin (API) Market Share by Application 2025 VS 2032 Figure 29. North America Guaifenesin (API) Sales Market Share in Volume by Application in 2025 Figure 30. North America Guaifenesin (API) Sales Market Share in Value by Application in 2025 Figure 31. Europe Guaifenesin (API) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Guaifenesin (API) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Guaifenesin (API) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Guaifenesin (API) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Guaifenesin (API) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Guaifenesin (API) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Guaifenesin (API) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Guaifenesin (API) Sales Market Share in Value by Application in 2025 Figure 39. North America Guaifenesin (API) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 40. North America Guaifenesin (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Guaifenesin (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Guaifenesin (API) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. Europe Guaifenesin (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Guaifenesin (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Guaifenesin (API) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Asia-Pacific Guaifenesin (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Guaifenesin (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Guaifenesin (API) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Latin America Guaifenesin (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Guaifenesin (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Guaifenesin (API) Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Middle East and Africa Guaifenesin (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Guaifenesin (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Guaifenesin (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Guaifenesin (API) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Guaifenesin (API) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 98%-99%
  • Above 99%
Applications
  • Pharmaceuticals
  • Others
Companies covered
  • Granules
  • Synthokem Labs
  • Haizhou Pharma
  • Yuan Cheng Group
  • Stellar Chemical
  • Seven Star Pharma
  • Gennex Lab
  • Iwaki Seiyaku
  • Pan Drugs
  • Delta Synthetic
  • Smart Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Guaifenesin (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Guaifenesin (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Guaifenesin (API) Market by Type
  6. 1.3.1 98%-99%
  7. 1.3.2 Above 99%
  8. 1.4 Global Guaifenesin (API) Market Size by Type
  9. 1.4.1 Global Guaifenesin (API) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Guaifenesin (API) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Guaifenesin (API) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Guaifenesin (API) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Guaifenesin (API) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Guaifenesin (API) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Guaifenesin (API) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Guaifenesin (API) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Guaifenesin (API) Industry Trends
  2. 2.2 Guaifenesin (API) Industry Drivers
  3. 2.3 Guaifenesin (API) Industry Opportunities and Challenges
  4. 2.4 Guaifenesin (API) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Guaifenesin (API) Revenue (2021-2026)
  2. 3.2 Global Top Players by Guaifenesin (API) Sales (2021-2026)
  3. 3.3 Global Top Players by Guaifenesin (API) Price (2021-2026)
  4. 3.4 Global Guaifenesin (API) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Guaifenesin (API) Major Company Production Sites & Headquarters
  6. 3.6 Global Guaifenesin (API) Company, Product Type & Application
  7. 3.7 Global Guaifenesin (API) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Guaifenesin (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Guaifenesin (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Guaifenesin (API) Tier 1, Tier 2, and Tier 3
4 Guaifenesin (API) Regional Status and Outlook
  1. 4.1 Global Guaifenesin (API) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Guaifenesin (API) Historic Market Size by Region
  3. 4.2.1 Global Guaifenesin (API) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Guaifenesin (API) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Guaifenesin (API) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Guaifenesin (API) Forecasted Market Size by Region
  7. 4.3.1 Global Guaifenesin (API) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Guaifenesin (API) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Guaifenesin (API) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Guaifenesin (API) by Application
  1. 5.1 Guaifenesin (API) Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Others
  4. 5.2 Global Guaifenesin (API) Market Size by Application
  5. 5.2.1 Global Guaifenesin (API) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Guaifenesin (API) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Guaifenesin (API) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Guaifenesin (API) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Guaifenesin (API) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Guaifenesin (API) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Guaifenesin (API) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Guaifenesin (API) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Granules
  2. 6.1.1 Granules Company Information
  3. 6.1.2 Granules Business Overview
  4. 6.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Granules Guaifenesin (API) Product Portfolio
  6. 6.1.5 Granules Recent Developments
  7. 6.2 Synthokem Labs
  8. 6.2.1 Synthokem Labs Company Information
  9. 6.2.2 Synthokem Labs Business Overview
  10. 6.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Synthokem Labs Guaifenesin (API) Product Portfolio
  12. 6.2.5 Synthokem Labs Recent Developments
  13. 6.3 Haizhou Pharma
  14. 6.3.1 Haizhou Pharma Company Information
  15. 6.3.2 Haizhou Pharma Business Overview
  16. 6.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Haizhou Pharma Guaifenesin (API) Product Portfolio
  18. 6.3.5 Haizhou Pharma Recent Developments
  19. 6.4 Yuan Cheng Group
  20. 6.4.1 Yuan Cheng Group Company Information
  21. 6.4.2 Yuan Cheng Group Business Overview
  22. 6.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yuan Cheng Group Guaifenesin (API) Product Portfolio
  24. 6.4.5 Yuan Cheng Group Recent Developments
  25. 6.5 Stellar Chemical
  26. 6.5.1 Stellar Chemical Company Information
  27. 6.5.2 Stellar Chemical Business Overview
  28. 6.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stellar Chemical Guaifenesin (API) Product Portfolio
  30. 6.5.5 Stellar Chemical Recent Developments
  31. 6.6 Seven Star Pharma
  32. 6.6.1 Seven Star Pharma Company Information
  33. 6.6.2 Seven Star Pharma Business Overview
  34. 6.6.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Seven Star Pharma Guaifenesin (API) Product Portfolio
  36. 6.6.5 Seven Star Pharma Recent Developments
  37. 6.7 Gennex Lab
  38. 6.7.1 Gennex Lab Company Information
  39. 6.7.2 Gennex Lab Business Overview
  40. 6.7.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gennex Lab Guaifenesin (API) Product Portfolio
  42. 6.7.5 Gennex Lab Recent Developments
  43. 6.8 Iwaki Seiyaku
  44. 6.8.1 Iwaki Seiyaku Company Information
  45. 6.8.2 Iwaki Seiyaku Business Overview
  46. 6.8.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Iwaki Seiyaku Guaifenesin (API) Product Portfolio
  48. 6.8.5 Iwaki Seiyaku Recent Developments
  49. 6.9 Pan Drugs
  50. 6.9.1 Pan Drugs Company Information
  51. 6.9.2 Pan Drugs Business Overview
  52. 6.9.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pan Drugs Guaifenesin (API) Product Portfolio
  54. 6.9.5 Pan Drugs Recent Developments
  55. 6.10 Delta Synthetic
  56. 6.10.1 Delta Synthetic Company Information
  57. 6.10.2 Delta Synthetic Business Overview
  58. 6.10.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Delta Synthetic Guaifenesin (API) Product Portfolio
  60. 6.10.5 Delta Synthetic Recent Developments
  61. 6.11 Smart Pharm
  62. 6.11.1 Smart Pharm Company Information
  63. 6.11.2 Smart Pharm Business Overview
  64. 6.11.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Smart Pharm Guaifenesin (API) Product Portfolio
  66. 6.11.5 Smart Pharm Recent Developments
7 North America by Country
  1. 7.1 North America Guaifenesin (API) Sales by Country
  2. 7.1.1 North America Guaifenesin (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Guaifenesin (API) Sales by Country (2021-2026)
  4. 7.1.3 North America Guaifenesin (API) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Guaifenesin (API) Market Size by Country
  6. 7.2.1 North America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Guaifenesin (API) Market Size by Country (2021-2026)
  8. 7.2.3 North America Guaifenesin (API) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Guaifenesin (API) Sales by Country
  2. 8.1.1 Europe Guaifenesin (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Guaifenesin (API) Sales by Country (2021-2026)
  4. 8.1.3 Europe Guaifenesin (API) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Guaifenesin (API) Market Size by Country
  6. 8.2.1 Europe Guaifenesin (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Guaifenesin (API) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Guaifenesin (API) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Guaifenesin (API) Sales by Country
  2. 9.1.1 Asia-Pacific Guaifenesin (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Guaifenesin (API) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Guaifenesin (API) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Guaifenesin (API) Market Size by Country
  6. 9.2.1 Asia-Pacific Guaifenesin (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Guaifenesin (API) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Guaifenesin (API) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Guaifenesin (API) Sales by Country
  2. 10.1.1 South America Guaifenesin (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Guaifenesin (API) Sales by Country (2021-2026)
  4. 10.1.3 South America Guaifenesin (API) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Guaifenesin (API) Market Size by Country
  6. 10.2.1 South America Guaifenesin (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Guaifenesin (API) Market Size by Country (2021-2026)
  8. 10.2.3 South America Guaifenesin (API) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Guaifenesin (API) Sales by Country
  2. 11.1.1 Middle East and Africa Guaifenesin (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Guaifenesin (API) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Guaifenesin (API) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Guaifenesin (API) Market Size by Country
  6. 11.2.1 Middle East and Africa Guaifenesin (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Guaifenesin (API) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Guaifenesin (API) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Guaifenesin (API) Value Chain Analysis
  2. 12.1.1 Guaifenesin (API) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Guaifenesin (API) Production Mode & Process
  7. 12.2 Guaifenesin (API) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Guaifenesin (API) Distributors
  10. 12.2.3 Guaifenesin (API) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst